Please Wait.....
Report
ResMed Inc. (RMD:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends
Company Report I 2024-07-12 I 91 Pages I Quaintel Research
Report Summary
ResMed Inc. (RMD:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends Report is a comprehensive and easily accessible overview of ResMed Inc.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about ResMed Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses ResMed Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of ResMed Inc.'s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers ResMed Inc.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares ResMed Inc.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by ResMed Inc. enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare industry. It operates through two main segments: Sleep and Respiratory Care, and Software as a Service. The company offers a variety of products and solutions for respiratory disorders, including technologies for medical and consumer applications. These include ventilation devices, diagnostic products, mask systems for both hospital and home use, headgear and other accessories, dental devices, and cloud-based software informatics solutions for managing patient outcomes. ResMed also provides customer and business process management solutions.
Key offerings include AirView, a cloud-based system for remote monitoring and adjustment of patients' device settings, and myAir, a personalized therapy management application for sleep apnea patients that offers support, education, and troubleshooting tools to enhance patient engagement and compliance. The company also offers U-Sleep, a compliance monitoring solution for home medical equipment (HME) providers, connectivity modules, Propeller solutions, and the Propeller portal.
ResMed's out-of-hospital software solutions include Brightree, which provides business management software and services to HME providers, pharmacies, home infusion, orthotics, and prosthetics services; MatrixCare, which offers care management and ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations; HEALTHCAREfirst, which provides electronic health records, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions.
The company markets its products through a network of distributors and direct sales forces to sleep clinics, home healthcare dealers, and hospitals. Founded in 1989, ResMed is headquartered in San Diego, California.
ResMed Inc. in the News:-
- 15-Mar-2024 - ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
- 06-Mar-2024 - Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed's Smallest Full-Face CPAP Mask
- 12-Feb-2024 - ResMed's New AirCurve 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
- 20-Dec-2023 - ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
- 11-Dec-2023 - ResMed Secures Significant Victory in Patent Fight Against New York University
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the ResMed Inc.'s internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company ResMed Inc.:
- ResMed Inc. Value Chain Analysis
- ResMed Inc. Porter's Five Forces Analysis
- ResMed Inc. VRIO Analysis
- ResMed Inc. BCG Analysis
- ResMed Inc. Segmentation, Targeting and Positioning (STP) Analysis
- ResMed Inc. Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 5
Charts 6
ResMed Inc. - Key Company Facts 7
ResMed Inc. - Company Description 8
ResMed Inc. - Top Executives 9
ResMed Inc.- Head Office & Locations 10
Head Office - Country 10
ResMed Inc. - Products and Services 11
Products 11
Services 12
ResMed Inc. - Corporate Strategy 13
ResMed Inc. - Business Description 19
Sleep and Respiratory Care 19
Software as a Service 20
ResMed Inc. - ESG Spotlight 22
Environment 22
Social 23
Corporate Governance 23
ResMed Inc. - SWOT Analysis 25
Overview 25
Strengths 27
Weaknesses 29
Opportunities 30
Threats 32
ResMed Inc. - PESTLE Analysis 34
Overview 34
Political Factors 36
Economic Factors 37
Social Factors 39
Technological Factors 41
Legal Factors 42
Environmental Factors 43
ResMed Inc. - Financial Deep Dive 44
Share Price Trend - Jul-2023 to Jul-2024 (Average Share Closing Price) 44
Profit and Loss Statement 46
Summary of Profit and Loss Statement 46
Balance Sheet 48
Summary of Balance Sheet 48
Cash Flow Statement 50
Summary of Cash Flow Statement 50
Key Financial Ratio Analysis 52
ResMed Inc. - Ratio Charts 53
Activity Ratio Charts 53
Growth Ratios Charts 54
Leverage Ratio Charts 55
Liquidity Ratio Charts 56
Profitability Ratio Charts 57
Competing Players 58
Snapshot of Competing Players 59
Koninklijke Philips N.V. 59
Key Company Facts 59
Company Description 59
Snapshot of Competing Players 61
Medtronic plc 61
Key Company Facts 61
Company Description 61
Snapshot of Competing Players 63
Hill-Rom Holdings Inc 63
Key Company Facts 63
Company Description 63
ResMed Inc. - In the News 64
15-Mar-2024 - ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis 64
06-Mar-2024 - Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed's Smallest Full-Face CPAP Mask 66
12-Feb-2024 - ResMed's New AirCurve 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea 67
20-Dec-2023 - ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices 69
11-Dec-2023 - ResMed Secures Significant Victory in Patent Fight Against New York University 71
09-Nov-2023 - ResMed Adopts New Operating Model to Accelerate Long-term Growth 72
05-Sep-2023 - ResMed Announces Participation in Upcoming Conferences 74
02-May-2023 - ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer 75
30-Mar-2023 - ResMed Chief Administrative Officer and Global General Counsel to Retire 76
6-Nov-2022 - ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health Solutions 76
06-Sep-2022 - ResMed Announces Participation in the Bank of America Global Healthcare Conference 77
ResMed Inc. - Key Deals 78
05-Jul-2023 - ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software 78
22-Nov-2022 - ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions 79
16-Aug-2022 - ResMed Commits to Investment of EUR30M in Research & Development in Ireland 80
02-Aug-2022 - ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio 81
14-Jun-2022 - ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions 83
Appendix 85
Definitions 85
SWOT Analysis 85
PESTLE Analysis 85
Value Chain Analysis 85
ESG Spotlight 85
Financial Deep Dive 85
Financial Ratios - 86
Activity Ratios 86
Growth Ratios 87
Leverage Ratios 88
Liquidity Ratios 89
Market Ratios 90
Profitability Ratios 90
Research Methodology 91
Disclaimer 92
Contact Us 92
Tables
Table 1: ResMed Inc. - Company Facts
Table 2: ResMed Inc. - Top Executives
Table 3: ResMed Inc. - Products
Table 4: ResMed Inc. - Services
Table 5: ResMed Inc. - Share Price Trend - Jul-2023 to Jul-2024
Table 6: ResMed Inc. - Ratio Analysis - 2020-2023
Table 7: ResMed Inc. - Competing Players
Charts
Figure 1: ResMed Inc.- SWOT Analysis 26
Figure 2: ResMed Inc. - PESTLE Analysis 35
Figure 3: ResMed Inc. - Average Share Price Trend - Jul-2023 to Jul-2024 45
Figure 4: ResMed Inc. - Profit and Loss Statement - 2020-2023 47
Figure 5: ResMed Inc. - Balance Sheet - 2020-2023 49
Figure 6: ResMed Inc. - Cash Flow Statement 2020-2023 51
Figure 7: ResMed Inc. - Activity Ratio Charts 53
Figure 8: ResMed Inc. - Growth Ratio Charts (Value %) 54
Figure 9: ResMed Inc. - Leverage Ratio Charts 55
Figure 10: ResMed Inc. - Liquidity Ratio Charts 56
Figure 11: ResMed Inc. - Profitability Ratio Charts (Value %) 57
Figure 12: Competing Players - Koninklijke Philips N.V. - Key Financials 60
Figure 13: Competing Players - Medtronic plc - Key Financials 62
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security